Selected research
Industry Research
Terlipressin Industry Research Report 2026
Market perspective
The global Terlipressin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Terlipressin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Terlipressin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Terlipressin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Terlipressin include Sun Pharmaceutical Industries Ltd., Hangzhou Huadi Group, Hybio Pharmaceutical, Xi 'an langene biological technology, Shanghai Soho-Yiming Pharmaceuticals, SGPharma, Maya Biotech and EVER Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Terlipressin market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Terlipressin Market by Company
Sun Pharmaceutical Industries Ltd.
Hangzhou Huadi Group
Hybio Pharmaceutical
Xi 'an langene biological technology
Shanghai Soho-Yiming Pharmaceuticals
SGPharma
Maya Biotech
EVER Pharma
Terlipressin Segment by Type
5ml vial Injections
10mL vial Injections
Terlipressin Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Terlipressin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Terlipressin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Terlipressin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Terlipressin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Terlipressin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Terlipressin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Terlipressin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5ml vial Injections
- 10mL vial Injections
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Companies covered
- Sun Pharmaceutical Industries Ltd.
- Hangzhou Huadi Group
- Hybio Pharmaceutical
- Xi 'an langene biological technology
- Shanghai Soho-Yiming Pharmaceuticals
- SGPharma
- Maya Biotech
- EVER Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Terlipressin Market Size (2021-2032)
- 2.2.2 Global Terlipressin Sales (2021-2032)
- 2.2.3 Global Terlipressin Market Average Price (2021-2032)
- 2.3 Terlipressin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5ml vial Injections
- 2.3.3 10mL vial Injections
- 2.4 Terlipressin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Retail Pharmacies
- 2.4.4 Online Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Terlipressin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Terlipressin Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Terlipressin Revenue of Manufacturers (2021-2026)
- 3.4 Global Terlipressin Average Price by Manufacturers (2021-2026)
- 3.5 Global Terlipressin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Terlipressin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Terlipressin, Product Type & Application
- 3.8 Global Manufacturers of Terlipressin, Established Date
- 3.9 Global Terlipressin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical Industries Ltd.
- 4.1.1 Sun Pharmaceutical Industries Ltd. Company Information
- 4.1.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 4.1.3 Sun Pharmaceutical Industries Ltd. Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Industries Ltd. Terlipressin Product Portfolio
- 4.1.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 4.2 Hangzhou Huadi Group
- 4.2.1 Hangzhou Huadi Group Company Information
- 4.2.2 Hangzhou Huadi Group Business Overview
- 4.2.3 Hangzhou Huadi Group Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hangzhou Huadi Group Terlipressin Product Portfolio
- 4.2.5 Hangzhou Huadi Group Recent Developments
- 4.3 Hybio Pharmaceutical
- 4.3.1 Hybio Pharmaceutical Company Information
- 4.3.2 Hybio Pharmaceutical Business Overview
- 4.3.3 Hybio Pharmaceutical Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hybio Pharmaceutical Terlipressin Product Portfolio
- 4.3.5 Hybio Pharmaceutical Recent Developments
- 4.4 Xi 'an langene biological technology
- 4.4.1 Xi 'an langene biological technology Company Information
- 4.4.2 Xi 'an langene biological technology Business Overview
- 4.4.3 Xi 'an langene biological technology Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Xi 'an langene biological technology Terlipressin Product Portfolio
- 4.4.5 Xi 'an langene biological technology Recent Developments
- 4.5 Shanghai Soho-Yiming Pharmaceuticals
- 4.5.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
- 4.5.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
- 4.5.3 Shanghai Soho-Yiming Pharmaceuticals Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai Soho-Yiming Pharmaceuticals Terlipressin Product Portfolio
- 4.5.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
- 4.6 SGPharma
- 4.6.1 SGPharma Company Information
- 4.6.2 SGPharma Business Overview
- 4.6.3 SGPharma Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SGPharma Terlipressin Product Portfolio
- 4.6.5 SGPharma Recent Developments
- 4.7 Maya Biotech
- 4.7.1 Maya Biotech Company Information
- 4.7.2 Maya Biotech Business Overview
- 4.7.3 Maya Biotech Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Maya Biotech Terlipressin Product Portfolio
- 4.7.5 Maya Biotech Recent Developments
- 4.8 EVER Pharma
- 4.8.1 EVER Pharma Company Information
- 4.8.2 EVER Pharma Business Overview
- 4.8.3 EVER Pharma Terlipressin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 EVER Pharma Terlipressin Product Portfolio
- 4.8.5 EVER Pharma Recent Developments
5 Global Terlipressin Market Scenario by Region
- 5.1 Global Terlipressin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Terlipressin Sales by Region: 2021-2032
- 5.2.1 Global Terlipressin Sales by Region: 2021-2026
- 5.2.2 Global Terlipressin Sales by Region: 2027-2032
- 5.3 Global Terlipressin Revenue by Region: 2021-2032
- 5.3.1 Global Terlipressin Revenue by Region: 2021-2026
- 5.3.2 Global Terlipressin Revenue by Region: 2027-2032
- 5.4 North America Terlipressin Market Facts & Figures by Country
- 5.4.1 North America Terlipressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Terlipressin Sales by Country (2021-2032)
- 5.4.3 North America Terlipressin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Terlipressin Market Facts & Figures by Country
- 5.5.1 Europe Terlipressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Terlipressin Sales by Country (2021-2032)
- 5.5.3 Europe Terlipressin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Terlipressin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Terlipressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Terlipressin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Terlipressin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Terlipressin Market Facts & Figures by Country
- 5.7.1 South America Terlipressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Terlipressin Sales by Country (2021-2032)
- 5.7.3 South America Terlipressin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Terlipressin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Terlipressin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Terlipressin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Terlipressin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Terlipressin Sales by Type (2021-2032)
- 6.1.1 Global Terlipressin Sales by Type (2021-2032) & (units)
- 6.1.2 Global Terlipressin Sales Market Share by Type (2021-2032)
- 6.2 Global Terlipressin Revenue by Type (2021-2032)
- 6.2.1 Global Terlipressin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Terlipressin Revenue Market Share by Type (2021-2032)
- 6.3 Global Terlipressin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Terlipressin Sales by Application (2021-2032)
- 7.1.1 Global Terlipressin Sales by Application (2021-2032) & (units)
- 7.1.2 Global Terlipressin Sales Market Share by Application (2021-2032)
- 7.2 Global Terlipressin Revenue by Application (2021-2032)
- 7.2.1 Global Terlipressin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Terlipressin Revenue Market Share by Application (2021-2032)
- 7.3 Global Terlipressin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Terlipressin Value Chain Analysis
- 8.1.1 Terlipressin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Terlipressin Production Mode & Process
- 8.2 Terlipressin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Terlipressin Distributors
- 8.2.3 Terlipressin Customers
9 Global Terlipressin Analyzing Market Dynamics
- 9.1 Terlipressin Industry Trends
- 9.2 Terlipressin Industry Drivers
- 9.3 Terlipressin Industry Opportunities and Challenges
- 9.4 Terlipressin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst